RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,957,861 | -15.7% | 177,970 | -5.2% | 0.00% | 0.0% |
| Q2 2023 | $3,509,598 | +9.9% | 187,679 | +7.8% | 0.00% | 0.0% |
| Q1 2023 | $3,194,056 | -18.5% | 174,063 | -12.0% | 0.00% | 0.0% |
| Q4 2022 | $3,918,024 | -1.8% | 197,880 | +19.3% | 0.00% | 0.0% |
| Q3 2022 | $3,991,000 | +681.0% | 165,844 | +493.1% | 0.00% | – |
| Q2 2022 | $511,000 | -54.0% | 27,961 | -44.7% | 0.00% | – |
| Q1 2022 | $1,112,000 | -16.5% | 50,602 | +39.5% | 0.00% | – |
| Q4 2021 | $1,332,000 | +35.9% | 36,261 | +14.9% | 0.00% | – |
| Q3 2021 | $980,000 | -61.9% | 31,563 | -61.0% | 0.00% | -100.0% |
| Q2 2021 | $2,569,000 | +1031.7% | 80,840 | +689.1% | 0.00% | – |
| Q1 2021 | $227,000 | -30.4% | 10,245 | -38.0% | 0.00% | – |
| Q4 2020 | $326,000 | -87.3% | 16,513 | -81.3% | 0.00% | -100.0% |
| Q2 2020 | $2,564,000 | – | 88,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |